Current Anti-Inflammatory Drugs, both over the counter and prescription have strong evidence suggesting abdominal issues with prolonged use associated with large dosing. Professionals and consumers alike have searched for many years looking for a more natural, less toxic option.

Studies show how our endogenous cannabinoid system (ECS) plays a protective role against several inflammatory complications. Evidence demonstrates cannabinoids’ ability to weaken smooth-muscular irritation and suppress non-antibody proteins. By managing our body’s cellular response to inflammation, scientists are approving cannabinoids like CBD as a safe, salutary alternative for inflammatory diseases

Furthermore, scientific studies currently indicate that CBD is naturally the most powerful anti-inflammatory that is produced organically; its strength seems to go beyond other substances like vitamin C, curcumin, omega-3, protelytics, and antioxidants. CBD activates CB2 cannabinoids receptors which typically regulate the body’s immunity. CBD hasn’t expressed any toxicity or unwanted side-effects; therefore, patients can administer CBD without any harm to liver, stomach lining, or kidneys. Today’s extraction process allows for the removal of THC in the cannabinoid. This allows the user to enjoy the health benefits without the worry of a psychoactive effect.


Contrary to popular belief, humans produce an endocannabinoid system with receptors that react designed for cannabinoids within the cannabis place. The principal endocannabinoid receptor is the CB1 receptor, which is situated the mind and throughout the anxious system.

A depressive disorder is rooted in your body’s nervous system and frequently related to a chemical substance imbalance in mind. While unhappiness can have various triggers, the medical community agrees in its potential to severely impact someone’s nervous system.

If the endocannabinoid system is overlooked, or out of homeostasis, lots of functions in the body are impacted, such as vitality, sleep patterns, feelings, and diet plan.


From infancy to seniority, millions of people worldwide live with epilepsy and take many different high-dose medications that can result in more adverse reactions. Scientific research identifies how naturally released cannabinoids within our bodies reduce and possibly prevent neurotoxicity leading to seizures.

Published evidence from clinical tests articulates CBD activity in the endocannabinoid system manages and sustains chronic and acute balances; this stasis is effective against seizures and lowers probability of death due to epilepsy. Further examination of CBD for epilepsy is ongoing; however, these studies successfully recognize the potential of cannabinoids treating neurological disorders and nerve injury.

Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604191/

Studies demonstrate cannabinoid compounds reducing the risk of seizures by stimulating the CB1 cannabinoid receptors located within the nervous system and in the areas of the brain that regulates memory. The data compiled from that observation suggests that epilepsy patients may receive a substantial benefit from CBD to prohibit and lower the occurrence of epileptic seizures.

Source: https://cbd-international.net/cbd-help-epileptic-seizures/


Scientific research has explored how CBD oil can strengthen kidney vitality by decreasing oxidative deterioration and inflammation related to kidney disease. Laboratory examinations with murine subjects advocated evidence of CBD compounds minimizing the detrimental effects of kidney damage developed from acute renal failure (ARF).

Along with clinical results, the study conveyed cannabinoid treatment increasingly lower oxidative harm from lipids and proteins; scientists also discovered that CBD directly affected the anti-inflammatory and antioxidant reactions within kidneys as opposed to a resultant function from cannabinoid receptor activation.

Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4738825/


Researchers have learned that the therapeutic qualities of the endocannabinoid system (ECS) can become hepatic, or correlate directly to the liver, at times. Activating the CB1 cannabinoid receptors with CBD oil showcased better fibrotic recovery from cirrhosis of the liver and balanced circulation of blood vessels.

Other hepatic effects of CB1 receptor stimulation exhibited strength reduction of alcoholic fatty liver but also an improvement opposite to insulin from large concentrations of cholesterol and lipids. In particular, results from a clinical observation suggested cannabinoid-based therapy had reduced risks of liver disease by restraining tissue damage, lessening inflammation associated with cytokines, and shrinking plasma discharges.

Source: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073545/


Scientists have determined that the endocannabinoid system (ECS) plays a vital role in managing our Body Mass Index (BMI), natural metabolism, and appetite. For instance, reports have detailed CBD diminishing cravings for particular foods by triggering CB1 cannabinoid receptors; other scientific findings describe the biphasic behaviors of cannabinoids when affecting cognitive systems. A common perception of cannabinoids is its ability to stimulate appetite; however, researchers have discovered that persistent activity from CB1 receptors can eventually weaken their potency which may cause an inverse response that suppresses hunger sensations.


Additional published studies have indicated the efficiency of CBD reducing the amount of fasting insulin; this function helps to prevent obesity and its related conditions by raising the level of high-density lipoprotein-cholesterol (HDL-C), also known as “good cholesterol,” while decreasing levels of insulin resistance. Furthermore, observational statistics illustrates how CBD improves weight control and lowering BMI by minimizing the amount of blood sugar.


Studies suggest that CBD has the capability of decreasing anxiety and stress regardless if it is slight or extreme. Research indicates CBD can transmit anxiolytic effects when activating CB1 cannabinoid receptors – such effects alter stress by brightening moods and balancing cognitive stability. The stimulation of cannabinoid receptors also naturally releases serotonin that reduces, relieves and soothes physical and mental tension. Because CBD is a non-psychoactive cannabinoid, preliminary evidence implies that CBD safely alters the limbic and paralimbic regions of the brain to reduce anxiety significantly. Scientists have shown that CBD can enhance or trigger pleasure hormones capable of calming the mind. This can act in a therapeutic manner for even latent health issues efficiently and safely that promotes no adverse side effects

Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691841/


Scientific evidence implies that CBD for cancer is an effective natural treatment, and because of its minor degree of toxicity, CBD is becoming an even more popular solution for cancer. A study from British pharmacology explains how CBD impedes cancer cells from expanding through the body; details indicate a stunt in cancerous growth and ultimately necrosis of cancer cells after significant administration of CBD. Other studies highlight the effectiveness of CBD as a long-term treatment particularly for breast cancer and leukemia with similar, positive results when also treating colon and lung cancer.

The research describes how CBD compounds react with the CB2 cannabinoid receptors found in the spleen – a base organ for the immune system. When these CB2 receptors become stimulated, they also activate the immune system; the composition of CBD is similar to our natural anandamide neurotransmitters which also stimulate CB2 receptors. An illness such as cancer requires more anandamide than the body can produce; CBD can supplement the demand and provide therapeutic balance. Once the CB2 receptors become regularly active, they can help against cancer cells.